Drugs / Gallium-68 PSMA-11
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03183544 | Jan 2019 → Feb 2020 | prostate neoplasm | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gallium-68 PSMA-11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03183544 ↗ |
| Modality | Diagnostic / imaging agent | “Single injection for diagnostic use only” NCT03183544 ↗ |